BIOLASE, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 2 rows in 2022. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-07-14: Reporting owner Sandor Steven; Form 3; Security Stock Option (right to buy); Transaction Holding.
- 2022-07-14: Reporting owner Bright Jennifer; Form 3; Security Stock Option (right to buy); Transaction Holding.
- 2020-05-13: Reporting owner Wagner Elaine C; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-05-13: Reporting owner Sato Garrett; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-07-14 holding as of filing | Sandor Steven Officer (Chief Operating Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $52.75 exercise price | 2022-07-14 | ||
| 2022-07-14 holding as of filing | Bright Jennifer Officer (Chief Financial Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $32.25 exercise price | 2022-07-14 |